Research And Development Tenders

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Interferon Beta-1B (Atc:L03ab08).

Development and Application of Pet and Spect Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of Cns Disorders (R01 Clinical Trial not Allowed)

Development and Application of Pet and Spect Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of Cns Disorders (R01 Clinical Trial Optional)

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Metoprolol and Hydrochlorothiazide (C07bb22).

Dynamic Purchasing System (Dps) for it Supplies (Dps Its)

Kymenlaakson Hva Support Activities of Social and Family Center Services for Children, Young People and Families

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Combination of Formoterol and Aclidinium Bromide (Atc Code: R03al05).

Dynamic Procurement System - Bolts

Rfr Dys Pos 2023-11 Hairdresser/ Barber Services

Nhs West Yorkshire Icb Domiciliary Care for Leeds Continuing Healthcare